欧洲慢性髓性白血病造血干细胞移植——成本考量的影响 - Suppr

Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe--impact of cost considerations.

作者信息

Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Urbano-Ispizua A, Frauendorfer K

出版信息

Leukemia. 2007 Mar;21(3):383-6. doi: 10.1038/sj.leu.2404509.

DOI:10.1038/sj.leu.2404509

PMID:17311065

Abstract

摘要

相似文献

Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe--impact of cost considerations.

Leukemia. 2007 Mar;21(3):383-6. doi: 10.1038/sj.leu.2404509.

Do affluent societies have the only options for the best therapy?

Leukemia. 2007 Mar;21(3):387-8. doi: 10.1038/sj.leu.2404534.

[The role of allogenic hematopoietic stem cell transplantation for chronic myeloid leukemia in imatinib era].

Gan To Kagaku Ryoho. 2011 May;38(5):759-64.

Is imatinib a cost-effective treatment for newly diagnosed chronic myeloid leukemia patients?

Nat Clin Pract Oncol. 2005 Mar;2(3):126-7. doi: 10.1038/ncponc0110.

Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?

Leuk Res. 2011 Jan;35(1):e11-2. doi: 10.1016/j.leukres.2010.09.014. Epub 2010 Oct 16.

Whither the bone marrow transplant?

Hematology. 2010 Feb;15(1):1-3. doi: 10.1179/102453310X12583347009892.

[Economic burden for patients with chronic myelogenous leukemia--healthcare economics and medical governance of cancer].

Gan To Kagaku Ryoho. 2010 Apr;37(4):577-81.

Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.

Cancer. 2004 Dec 1;101(11):2574-83. doi: 10.1002/cncr.20694.

Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.

Expert Rev Anticancer Ther. 2007 Mar;7(3):249-51. doi: 10.1586/14737140.7.3.249.

Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.

Leukemia. 2003 Sep;17(9):1722. doi: 10.1038/sj.leu.2403072.

引用本文的文献

Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France.

Haematologica. 2014 Mar;99(3):535-40. doi: 10.3324/haematol.2013.092254. Epub 2013 Oct 18.

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.

Haematologica. 2013 Aug;98(8):1282-90. doi: 10.3324/haematol.2012.076349. Epub 2013 Mar 18.

Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.

Hematol Oncol Clin North Am. 2011 Oct;25(5):1025-48, vi. doi: 10.1016/j.hoc.2011.09.003.

Hematopoietic stem cell transplantation: a global perspective.

JAMA. 2010 Apr 28;303(16):1617-24. doi: 10.1001/jama.2010.491.

Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology.

Haematologica. 2010 Apr;95(4):637-43. doi: 10.3324/haematol.2009.015586.

Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report.

Bone Marrow Transplant. 2009 Jan;43(1):1-12. doi: 10.1038/bmt.2008.389. Epub 2008 Dec 1.

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

Blood. 2008 Oct 15;112(8):3500-7. doi: 10.1182/blood-2008-02-141689. Epub 2008 Jul 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe--impact of cost considerations.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献